<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36369815</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2042-8189</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The journal of the Royal College of Physicians of Edinburgh</Title><ISOAbbreviation>J R Coll Physicians Edinb</ISOAbbreviation></Journal><ArticleTitle>Clinical outcomes at medium-term follow-up of COVID-19.</ArticleTitle><Pagination><StartPage>220</StartPage><EndPage>227</EndPage><MedlinePgn>220-227</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/14782715221124617</ELocationID><Abstract><AbstractText Label="BACKGROUND">The long coronavirus disease 2019 (COVID-19) syndrome is defined as persistent physical, cognitive and/or psychological symptoms that continue for more than 12&#x2009;weeks following the acute illness.</AbstractText><AbstractText Label="METHODS">In all, 2,646 patients were randomly selected from all individuals who were diagnosed with COVID-19. They were interviewed so as to assess the persistence of symptoms and health-related quality of life. Blood investigations were also taken.</AbstractText><AbstractText Label="RESULTS">The median (interquartile range (IQR)) age was 44 (31-55) years and 48.6% were males. Five per cent had been hospitalised. Follow-up was for a median of 142&#x2009;days (IQR: 128-161). Twenty-two per cent of the participants claimed that they were feeling worse than they felt before COVID-19. The most common symptoms were anosmia, ageusia, fatigue, shortness of breath, headaches and myalgia. The Short Form-36 questionnaire revealed that 16.4% felt that they were somewhat worse than in the previous year and that hospitalised patients fared worse in all domains except for role-emotional. New-onset diabetes was similar to the rate of undiagnosed diabetes in the background population. Hospitalised patients had significantly higher liver transaminases, fasting plasma glucose, glycated haemoglobin, uric acid, red cell distribution width, mean platelet volume, triglyceride levels and troponin levels but lower estimated glomerular filtration rate and high-density lipoprotein-cholesterol at follow-up.</AbstractText><AbstractText Label="DISCUSSION">A significant proportion of patients were symptomatic at a median follow-up of 142&#x2009;days and felt worse than 1&#x2009;year previously. Hospitalised patients had more biochemical and haematological abnormalities compared to non-hospitalised ones, suggesting ongoing inflammation in subjects who were more severely affected by the disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barbara</LastName><ForeName>Jessica-Marie</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gatt</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xuereb</LastName><ForeName>Rachel-Anne</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Malta Medical School, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabone Adami</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darmanin</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erasmi</LastName><ForeName>Renee</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G Xuereb</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Malta Medical School, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbara</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Malta Medical School, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephen</LastName><ForeName>Fava</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Malta Medical School, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jane Magri</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Malta Medical School, Msida, Malta.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J R Coll Physicians Edinb</MedlineTA><NlmUniqueID>101144324</NlmUniqueID><ISSNLinking>1478-2715</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SF36</Keyword><Keyword MajorTopicYN="N">health-related quality of life</Keyword><Keyword MajorTopicYN="N">long COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">mean platelet volume</Keyword><Keyword MajorTopicYN="N">red cell distribution width</Keyword></KeywordList><CoiStatement>The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>2</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36369815</ArticleId><ArticleId IdType="pmc">PMC9478632</ArticleId><ArticleId IdType="doi">10.1177/14782715221124617</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organisation. WHO Coronavirus (2022, COVID-19) dashboard, https://covid19.who.int/ (accessed 21 August 2022).</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN), Royal College of General Practitioners (RCGP). COVID-19 rapid guideline: managing the longterm effects of COVID-19, https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742 (2022, accessed 21 August 2022).</Citation></Reference><Reference><Citation>Jennings G, Monaghan A, Xue F, et al.A systematic review of persistent symptoms and residual abnormal functioning following acute COVID-19: ongoing symptomatic phase vs. post-COVID-19 syndrome. J Clin Med 2021; 10: 5913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8708187</ArticleId><ArticleId IdType="pubmed">34945213</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al.6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397: 220-32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S, Benatti SV, Casati M, et al.Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol Infect 2021; 149: e32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE, Snow KK, Kosinski M, et al.SF-36&#xae; Health survey manual and interpretation guide. Boston, MA: New England Medical Center, The Health Institute; 1993.</Citation></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al.Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect 2021; 27: 258&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes UK.Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. https://www.diabetes.org.uk/resources-s3/2017-09/hba1c_diagnosis.1111.pdf (2011, accessed 20 August 2022).</Citation></Reference><Reference><Citation>McHorney CA, Ware JE, Jr, Lu JF, et al.The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32: 40&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">8277801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosinski M, Keller SD, Hatoum HT, et al.The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data quality, scaling assumptions and score reliability. Med Care 1999; 37: MS10&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">10335740</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaspar R, Castelo Branco C, Macedo G.Liver and COVID-19: from care of patients with liver diseases to liver injury. World J Hepatol 2021; 13: 1367&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8568576</ArticleId><ArticleId IdType="pubmed">34786172</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Fan JG.Characteristics and mechanism of liver injury in 2019 coronavirus disease. J Clin Transl Hepatol 2020; 8: 13&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7132021</ArticleId><ArticleId IdType="pubmed">32274341</ArticleId></ArticleIdList></Reference><Reference><Citation>Hundt MA, Deng Y, Ciarleglio MM, et al.Abnormal liver tests in COVID-19: a retrospective observational cohort study of 1,827 patients in a major U.S. hospital network. Hepatology 2020; 72: 1169&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9258788</ArticleId><ArticleId IdType="pubmed">32725890</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei F, Liu YM, Zhou F, et al.Longitudinal association between markers of liver injury and mortality in COVID-19 in China. Hepatology 2020; 72: 389&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267515</ArticleId><ArticleId IdType="pubmed">32359177</ArticleId></ArticleIdList></Reference><Reference><Citation>Magri CJ, Tian TX, Camilleri L, et al.Red blood cell distribution width and myocardial scar burden in coronary artery disease. Postgrad Med J 2017; 93: 607&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">28490545</ArticleId></ArticleIdList></Reference><Reference><Citation>Born&#xe9; Y, Smith JG, Melander O, et al.Red cell distribution width in relation to incidence of coronary events and case fatality rates: a population-based cohort study. Heart 2014; 100: 1119&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">24760701</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonelli M, Sacks F, Arnold M, et al.; for the Cholesterol and Recurrent Events (CARE) Trial Investigators. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008; 117: 163&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18172029</ArticleId></ArticleIdList></Reference><Reference><Citation>Magri CJ, Fava S.Red blood cell distribution width and diabetes-associated complications. Diabetes Metab Syndr 2014; 8: 13&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24661752</ArticleId></ArticleIdList></Reference><Reference><Citation>Pafili K, Penlioglou T, Mikhailidis DP, et al.Mean platelet volume and coronary artery disease. Curr Opin Cardiol 2019; 34: 390&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30950847</ArticleId></ArticleIdList></Reference><Reference><Citation>Nozari Y, Parsa M, Jalali A, et al.Mean platelet volume and major adverse cardiac events following percutaneous coronary intervention. Arch Iran Med 2019; 22: 198&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">31126178</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Molnar MZ, Fonarow GC, et al.Mean platelet volume and mortality risk in a national incident hemodialysis cohort. Int J Cardiol 2016; 220: 862&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5929115</ArticleId><ArticleId IdType="pubmed">27400185</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;&#xe7;l&#xfc; E, Kocayi&#x11f;it H, Okan HD, et al.Effect of COVID-19 on platelet count and its indices. Rev Assoc Med Bras (1992) 2020; 66: 1122&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32935808</ArticleId></ArticleIdList></Reference><Reference><Citation>Atik D, Kaya HB.Evaluation of the relationship of MPV, RDW AND PVI parameters with disease severity in COVID-19 patients. Acta Clin Croat 2021; 60: 103&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8305345</ArticleId><ArticleId IdType="pubmed">34588729</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeraiby MA, Hakamy MI, Albarqi MB, et al.Routine laboratory parameters predict serious outcome as well as length of hospital stay in COVID-19. Saudi Med J 2021; 42: 1165&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9149729</ArticleId><ArticleId IdType="pubmed">34732547</ArticleId></ArticleIdList></Reference><Reference><Citation>Foy BH, Carlson JCT, Reinertsen E, et al.Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection. JAMA Netw Open 2020; 3: e2022058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7512057</ArticleId><ArticleId IdType="pubmed">32965501</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry BM, Benoit JL, Benoit S, et al.Red blood cell distribution width (RDW) predicts COVID-19 severity: a prospective, observational study from the Cincinnati SARS-CoV-2 emergency department cohort. Diagnostics (Basel) 2020; 10: 618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7554711</ArticleId><ArticleId IdType="pubmed">32825629</ArticleId></ArticleIdList></Reference><Reference><Citation>Caro-Cod&#xf3;n J, Rey JR, Bu&#xf1;o A, et al.; CARD-COVID Investigators. Characterization of myocardial injury in a cohort of patients with SARS-CoV-2 infection. Med Clin (Engl Ed) 2021; 157: 274&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8451250</ArticleId><ArticleId IdType="pubmed">34568576</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehman S, Rehman N, Mumtaz A, et al.Association of mortality-related risk factors in patients with COVID-19: a retrospective cohort study. Healthcare (Basel) 2021; 9: 1468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8619090</ArticleId><ArticleId IdType="pubmed">34828513</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Liao X, Yin W, et al.; Study of 2019 Novel Coronavirus Pneumonia Infected Critically Ill Patients in Sichuan Province (SUNRISE) Group. Elevated cardiac biomarkers may be effective prognostic predictors for patients with COVID-19: a multicenter, observational study. Am J Emerg Med 2020; 39: 34&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7553004</ArticleId><ArticleId IdType="pubmed">34756391</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Zhou L, Sun X, et al.Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep 2017; 7: 9110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5567209</ArticleId><ArticleId IdType="pubmed">28831119</ArticleId></ArticleIdList></Reference><Reference><Citation>Barman HA, Pala AS, Dogan O, et al.Prognostic significance of temporal changes of lipid profile in COVID-19 patients. Obes Med 2021; 28: 100373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8516440</ArticleId><ArticleId IdType="pubmed">34671707</ArticleId></ArticleIdList></Reference><Reference><Citation>Masana L, Correig E, Ibarretxe D, et al.; STACOV-XULA Research Group. Low HDL and high triglycerides predict COVID-19 severity. Sci Rep 2021; 11: 7217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010012</ArticleId><ArticleId IdType="pubmed">33785815</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuschieri S, Vassallo J, Calleja N, et al.The diabesity health economic crisis-the size of the crisis in a European island state following a cross-sectional study. Arch Public Health 2016; 74: 52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5151145</ArticleId><ArticleId IdType="pubmed">27999669</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Kapoor N, Cao Y, et al.Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab 2021; 23: 870&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753574</ArticleId><ArticleId IdType="pubmed">33245182</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampasona V, Secchi M, Scavini M, et al.Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study. Diabetologia 2020; 63: 2548&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7541098</ArticleId><ArticleId IdType="pubmed">33029657</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Tian S, Chen T, et al.Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes Obes Metab 2020; 22: 1897&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283710</ArticleId><ArticleId IdType="pubmed">32469464</ArticleId></ArticleIdList></Reference><Reference><Citation>Fadini GP, Morieri ML, Boscari F, et al.Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration. Diabetes Res Clin Pract 2020; 168: 108374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7428425</ArticleId><ArticleId IdType="pubmed">32805345</ArticleId></ArticleIdList></Reference><Reference><Citation>Saiki A, Ohira M, Endo K, et al.Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus. Metabolism 2009; 58: 708&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">19375596</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JK, Lin SS, Ji XJ, et al.Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 2010; 47: 193&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7088164</ArticleId><ArticleId IdType="pubmed">19333547</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabri S, Bourron O, Phan F, et al.Interactions between diabetes and COVID-19: a narrative review. World J Diabetes 2021; 12: 1674&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8554367</ArticleId><ArticleId IdType="pubmed">34754370</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>